PubMed

The Danish PEP Registry: Experience With the Use of Postexposure Prophylaxis (PEP) Following Sexual Exposure to HIV From 1998 to 2006.

Lunding S, Katzenstein TL, Kronborg G, Lindberg JA, Jensen J, Nielsen HI, Pedersen C, Jørgensen LB.

Sex Transm Dis. 2009 Sep 3. [Epub ahead of print]PMID: 19734819 [PubMed - as supplied by publisher]Related articles

Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.

Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.

Scand J Immunol. 2008 Dec;68(6):652-60.PMID: 19055701 [PubMed - indexed for MEDLINE]Related articles

Zidovudine monotherapy in pregnancy: is it state of the art?

Katzenstein TL, Gerstoft J.

HIV Med. 2008 Aug;9(7):445-7. No abstract available. PMID: 18840149 [PubMed - indexed for MEDLINE]Related articles

[Picture of the month: neurocysticercosis]

Nielsen CT, Katzenstein TL, Hallam DM.

Ugeskr Laeger. 2008 Aug 25;170(35):2707. Danish. No abstract available. PMID: 18761863 [PubMed - indexed for MEDLINE]Related articles

Seventeen-year-old mother-to-child HIV type 1 transmission identified by phylogeny and signature patterns.

Katzenstein TL, Petersen AB, Jørgensen LB, Strand TJ, Madsen TV, Gerstoft J.

AIDS Res Hum Retroviruses. 2008 Aug;24(8):1117-20.PMID: 18671456 [PubMed - indexed for MEDLINE]Related articles

p24 as a predictor of mortality in a cohort of HIV-1-infected adults in rural Africa.

Erikstrup C, Kallestrup P, Zinyama-Gutsire RB, Gomo E, Lüneborg-Nielsen M, Gerstoft J, Schüpbach J, Ullum H, Katzenstein TL.

J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):345-9.PMID: 18545150 [PubMed - indexed for MEDLINE]Related articles

Investigating signs of recent evolution in the pool of proviral HIV type 1 DNA during years of successful HAART.

Mens H, Pedersen AG, Jørgensen LB, Hue S, Yang Y, Gerstoft J, Katzenstein TL.

AIDS Res Hum Retroviruses. 2007 Jan;23(1):107-15.PMID: 17263640 [PubMed - indexed for MEDLINE]Related articles

No influence of GB virus C on disease progression in a Danish cohort of HIV-infected men.

Ryt-Hansen R, Katzenstein TL, Gerstoft J, Eugen-Olsen J.

AIDS Res Hum Retroviruses. 2006 Jun;22(6):496-8.PMID: 16796523 [PubMed - indexed for MEDLINE]Related articles

Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy.

Ostrowski SR, Katzenstein TL, Pedersen M, Høyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H.

Scand J Immunol. 2006 Jun;63(6):478-86.PMID: 16764702 [PubMed - indexed for MEDLINE]Related articles

Dynamics of proviral HIV-1 184M/V in circulating CD4+ T-cells: a 90 days follow-up study after initiation/switch of HAART.

Mohey R, Katzenstein TL, Black FT, Kjems J, Obel N.

Scand J Infect Dis. 2006;38(2):119-23.PMID: 16449003 [PubMed - indexed for MEDLINE]Related articles

Genetic evolution of HIV in patients remaining on a stable HAART regimen despite insufficient viral suppression.

Kristiansen TB, Pedersen AG, Eugen-Olsen J, Katzenstein TL, Lundgren JD.

Scand J Infect Dis. 2005;37(11-12):890-901.PMID: 16308226 [PubMed - indexed for MEDLINE]Related articles

[Hepatic failure due to nevirapine treatment for HIV infection]

Mens H, Katzenstein TL.

Ugeskr Laeger. 2005 Nov 14;167(46):4359. Danish. PMID: 16287519 [PubMed - indexed for MEDLINE]Related articles

[Organ transplants for HIV-infected patients--time for reevaluation?]

Katzenstein TL.

Ugeskr Laeger. 2005 Nov 14;167(46):4356-8. Danish. PMID: 16287518 [PubMed - indexed for MEDLINE]Related articles

Hepatitis A outbreak among MSM linked to casual sex and gay saunas in Copenhagen, Denmark.

Mazick A, Howitz M, Rex S, Jensen IP, Weis N, Katzenstein TL, Haff J, Molbak K.

Euro Surveill. 2005 May;10(5):111-4.PMID: 16077208 [PubMed - indexed for MEDLINE]Related articlesFree article

2B4 expression on natural killer cells increases in HIV-1 infected patients followed prospectively during highly active antiretroviral therapy.

Ostrowski SR, Ullum H, Pedersen BK, Gerstoft J, Katzenstein TL.

Clin Exp Immunol. 2005 Sep;141(3):526-33.PMID: 16045743 [PubMed - indexed for MEDLINE]Related articlesFree article

Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy.

Ostrowski SR, Katzenstein TL, Thim PT, Pedersen BK, Gerstoft J, Ullum H.

J Infect Dis. 2005 Feb 1;191(3):348-57. Epub 2004 Dec 30.PMID: 15633093 [PubMed - indexed for MEDLINE]Related articles

Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study.

Røge BT, Barfod TS, Kirk O, Katzenstein TL, Obel N, Nielsen H, Pedersen C, Mathiesen LR, Lundgren JD, Gerstoft J.

HIV Med. 2004 Sep;5(5):344-51.PMID: 15369509 [PubMed - indexed for MEDLINE]Related articles

Tenofovir treatment in an unselected cohort of highly antiretroviral experienced HIV positive patients.

Lerbaek A, Kristiansen TB, Katzenstein TL, Mathiesen L, Gerstoft J, Nielsen C, Larsen K, Nielsen JO, Obel N, Laursen AL, Nielsen SD.

Scand J Infect Dis. 2004;36(4):280-6.PMID: 15198185 [PubMed - indexed for MEDLINE]Related articles

Soluble urokinase receptor levels in plasma during 5 years of highly active antiretroviral therapy in HIV-1-infected patients.

Ostrowski SR, Katzenstein TL, Piironen T, Gerstoft J, Pedersen BK, Ullum H.

J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):337-42.PMID: 15097149 [PubMed - indexed for MEDLINE]Related articles

A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors.

Kirk O, Lundgren JD, Pedersen C, Mathiesen LR, Nielsen H, Katzenstein TL, Obel N, Gerstoft J.

Antivir Ther. 2003 Dec;8(6):595-602.PMID: 14760893 [PubMed - indexed for MEDLINE]Related articles

Molecular biological assessment methods and understanding the course of the HIV infection.

Katzenstein TL.

APMIS Suppl. 2003;(114):1-37. Review.PMID: 14626050 [PubMed - indexed for MEDLINE]Related articles

Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.

Gerstoft J, Kirk O, Obel N, Pedersen C, Mathiesen L, Nielsen H, Katzenstein TL, Lundgren JD.

AIDS. 2003 Sep 26;17(14):2045-52.PMID: 14502007 [PubMed - indexed for MEDLINE]Related articles

K65R with and without S68: a new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine.

Røge BT, Katzenstein TL, Obel N, Nielsen H, Kirk O, Pedersen C, Mathiesen L, Lundgren J, Gerstoft J.

Antivir Ther. 2003 Apr;8(2):173-82.PMID: 12741630 [PubMed - indexed for MEDLINE]Related articles

Virological and immunological profiles among patients with undetectable viral load followed prospectively for 24 months.

Katzenstein TL, Ullum H, Røge BT, Wandall J, Dickmeiss E, Barrington T, Skinhøj P, Gerstoft J.

HIV Med. 2003 Jan;4(1):53-61.PMID: 12534960 [PubMed - indexed for MEDLINE]Related articles

Drug resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART.

Røge BT, Katzenstein TL, Nielsen HL, Gerstoft J.

HIV Med. 2003 Jan;4(1):38-47.PMID: 12534958 [PubMed - indexed for MEDLINE]Related articles

Clinical lipoatrophy in HIV-1 patients on HAART is not associated with increased abdominal girth, hyperlipidaemia or glucose intolerance.

Worm D, Kirk O, Andersen O, Vinten J, Gerstoft J, Katzenstein TL, Nielsen H, Pedersen C.

HIV Med. 2002 Oct;3(4):239-46.PMID: 12444941 [PubMed - indexed for MEDLINE]Related articles

Cell-associated HIV DNA measured early during infection has prognostic value independent of serum HIV RNA measured concomitantly.

Katzenstein TL, Oliveri RS, Benfield T, Eugen-Olsen J, Nielsen C, Gerstoft J; Copenhagen AIDS Cohort Study Group.

Scand J Infect Dis. 2002;34(7):529-33.PMID: 12195879 [PubMed - indexed for MEDLINE]Related articles

Low body weight and type of protease inhibitor predict discontinuation and treatment-limiting adverse drug reactions among HIV-infected patients starting a protease inhibitor regimen: consistent results from a randomized trial and an observational cohort.

Kirk O, Gerstoft J, Pedersen C, Nielsen H, Obel N, Katzenstein TL, Mathiesen L, Lundgren JD.

HIV Med. 2001 Jan;2(1):43-51.PMID: 11737375 [PubMed - indexed for MEDLINE]Related articles

Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.

Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen J, Gallart T, Katzenstein TL, Kostrikis LG, Kuipers H, Louie LG, Mallal SA, Margolick JB, Martinez OP, Meyer L, Michael NL, Operskalski E, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Stewart GJ, Theodorou ID, Ullum H, Vicenzi E, Vlahov D, Wilkinson D, Workman C, Zagury JF, O'Brien TR; International Meta-Analysis of HIV Host Genetics.

Ann Intern Med. 2001 Nov 6;135(9):782-95.PMID: 11694103 [PubMed - indexed for MEDLINE]Related articlesFree article

Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression.

Knudsen TB, Kristiansen TB, Katzenstein TL, Eugen-Olsen J; Copenhagen AIDS Study Group.

J Med Virol. 2001 Nov;65(3):441-4.PMID: 11596075 [PubMed - indexed for MEDLINE]Related articles

[No development of HIV infection after transfusion with HIV-contaminated blood and postexposure antiviral prevention]

Katzenstein TL, Dickmeiss E, Aladdin H, Hede A, Nielsen C, Nielsen H, Jørgensen LB, Gerstoft J.

Ugeskr Laeger. 2001 May 7;163(19):2635-7. Danish. PMID: 11360358 [PubMed - indexed for MEDLINE]Related articles

Comparison of P-triglyceride levels among patients with human immunodeficiency virus on randomized treatment with ritonavir, indinavir or ritonavir/saquinavir.

Røge BT, Katzenstein TL, Gerstoft J.

Scand J Infect Dis. 2001;33(4):306-11.PMID: 11345223 [PubMed - indexed for MEDLINE]Related articles

Genotypic and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine.

Jørgensen LB, Katzenstein TL, Gerstoft J, Mathiesen LR, Pedersen C, Nielsen C.

Antivir Ther. 2000 Sep;5(3):187-94.PMID: 11075938 [PubMed - indexed for MEDLINE]Related articles

Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels.

Ullum H, Lepri AC, Katzenstein TL, Phillips AN, Skinhøj P, Gerstoft J, Pedersen BK.

Scand J Infect Dis. 2000;32(4):371-6.PMID: 10959644 [PubMed - indexed for MEDLINE]Related articles

The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection.

Katzenstein TL, Kirk O, Pedersen C, Lundgren JD, Nielsen H, Obel N, Nielsen C, Mathiesen LR, Gerstoft J.

J Infect Dis. 2000 Sep;182(3):744-50. Epub 2000 Aug 3.PMID: 10950767 [PubMed - indexed for MEDLINE]Related articles

Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis.

Katzenstein TL, Dickmeiss E, Aladdin H, Hede A, Nielsen C, Nielsen H, Jørgensen LB, Gerstoft J.

Ann Intern Med. 2000 Jul 4;133(1):31-4. No abstract available. PMID: 10877737 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study.

Paredes R, Mocroft A, Kirk O, Lazzarin A, Barton SE, van Lunzen J, Katzenstein TL, Antunes F, Lundgren JD, Clotet B.

Arch Intern Med. 2000 Apr 24;160(8):1123-32.PMID: 10789605 [PubMed - indexed for MEDLINE]Related articlesFree article

Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trial.

Aladdin H, Ullum H, Dam Nielsen S, Espersen C, Mathiesen L, Katzenstein TL, Gerstoft J, Skinhoj P, Pedersen BK.

J Infect Dis. 2000 Mar;181(3):1148-52.PMID: 10720544 [PubMed - indexed for MEDLINE]Related articles

[Nosocomial HIV transmission at a Danish hospital department]

Katzenstein TL, Nielsen C, Gerstoft J.

Ugeskr Laeger. 1999 Nov 15;161(46):6364-5. Danish. No abstract available. PMID: 10611838 [PubMed - indexed for MEDLINE]Related articles

Nosocomial HIV-transmission in an outpatient clinic detected by epidemiological and phylogenetic analyses.

Katzenstein TL, Jørgensen LB, Permin H, Hansen J, Nielsen C, Machuca R, Gerstoft J.

AIDS. 1999 Sep 10;13(13):1737-44.PMID: 10509576 [PubMed - indexed for MEDLINE]Related articles

Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial.

Kirk O, Katzenstein TL, Gerstoft J, Mathiesen L, Nielsen H, Pedersen C, Lundgren JD.

AIDS. 1999 Jan 14;13(1):F9-16.PMID: 10207539 [PubMed - indexed for MEDLINE]Related articles

Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study Group.

Kirk O, Mocroft A, Katzenstein TL, Lazzarin A, Antunes F, Francioli P, Brettle RP, Parkin JM, Gonzales-Lahoz J, Lundgren JD.

AIDS. 1998 Oct 22;12(15):2031-9.PMID: 9814872 [PubMed - indexed for MEDLINE]Related articles

The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection.

Cozzi Lepri A, Katzenstein TL, Ullum H, Phillips AN, Skinhøj P, Gerstoft J, Pedersen BK.

AIDS. 1998 Sep 10;12(13):1639-43.PMID: 9764783 [PubMed - indexed for MEDLINE]Related articles

[Toxoplasma encephalitis with atypical manifestation and normal CT]

Katzenstein TL, Oster S, Kiss K.

Ugeskr Laeger. 1998 Jul 20;160(30):4430-2. Danish. PMID: 9691837 [PubMed - indexed for MEDLINE]Related articles

[HIV quantification--how and why]

Katzenstein TL, Pedersen C, Gerstoft J.

Ugeskr Laeger. 1997 Dec 29;160(1):18-24. Review. Danish. PMID: 9446260 [PubMed - indexed for MEDLINE]Related articles

HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group.

Katzenstein TL, Eugen-Olsen J, Hofmann B, Benfield T, Pedersen C, Iversen AK, Sørensen AM, Garred P, Koppelhus U, Svejgaard A, Gerstoft J.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Sep 1;16(1):10-4.PMID: 9377119 [PubMed - indexed for MEDLINE]Related articles

Pneumococcal vaccination of HIV-infected individuals: safety and efficacy.

Katzenstein TL.

AIDS Patient Care STDS. 1997 Aug;11(4):269-75. Review.PMID: 11361841 [PubMed - indexed for MEDLINE]Related articles

Decreased short-term production of tumor necrosis factor-alpha and interleukin-1beta in human immunodeficiency virus-seropositive subjects.

Ullum H, Victor J, Katzenstein TL, Gerstoft J, Gøtzsche PC, Bendtzen K, Skinhøj P, Pedersen BK.

J Infect Dis. 1997 Jun;175(6):1507-10.PMID: 9180195 [PubMed - indexed for MEDLINE]Related articles

Quantification of HIV-1 RNA during antiretroviral therapy: association with viral phenotype and development of resistance.

Katzenstein TL, Nielsen C, Bruun L, Mathiesen LR, Pedersen C, Gerstoft J.

Antivir Ther. 1996 Dec;1(4):246-54.PMID: 11324827 [PubMed - indexed for MEDLINE]Related articles

Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome.

Katzenstein TL, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J.

AIDS. 1996 Feb;10(2):167-73.PMID: 8838704 [PubMed - indexed for MEDLINE]Related articles